ISCCA Recommendations on Clinical, Physical Evidence on Survivorship and Caregivers’ Preference for Common In-Vivo Medication

The goal of these meetings is to provide an optimal environment for advancing lifesaving research towards impactful clinical, translational, and societal outcomes.
Boehm said recommendations for the pharmacists the submitted were reflective of a number of stakeholders.
Boehm cited incidence of suicidal ideation, use of cheap nonopioid medications, affordability of medications, and high-adverse drug events, among others, as reasons for the organization’s current recommendation.
Boehm also cited counseling beliefs, activation behavior, medication tolerance, change of diagnosis in line with new clinical findings, voice bias, residual effects, and opioid dependence.
He encouraged participants to reach out to him if interested.

Read More